Smith and Nephew forms joint venture

Smith and Nephew, the medical technology business, has agreed to form a joint venture with Essex Woodlands, a specialist healthcare growth equity and venture capital firm, to further develop its Biologics and Clinical Therapies division. The new entity, called Bioventus, will be 51% owned by Essex Woodlands and 49% by Smith & Nephew.